Cambridge Investment Research Advisors, Inc.

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1419186 FAIRFIELD, IA

Back to BCRX Full portfolio

Position in BCRX

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$198,530

-$24,456 QoQ

Shares Held

19,853

-15.2% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#208

of 316 holders

Holding Since

Jun 2020

11 quarters on record

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Cambridge Investment Research Advisors, Inc. holds $28,058,357 across 19 Drug Manufacturers - Specialty & Generic names. BCRX ranks #14 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LNTH	Lantheus Holdings, Inc.	64,199	$7,122,237
2	PCRX	Pacira BioSciences, Inc.	127,996	$3,247,258
3	UTHR	UNITED THERAPEUTICS Corp	5,625	$3,047,793
4	TEVA	Teva Pharmaceutical Industries Ltd	87,650	$2,969,582
5	HIMS	Hims & Hers Health, Inc.	79,024	$2,739,762
6	ZTS	Zoetis Inc.	34,463	$2,476,511
7	VTRS	Viatris Inc	140,952	$2,238,317
8	NBIX	Neurocrine Biosciences Inc	6,718	$1,132,251

All Filings in BCRX

Export CSV

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$198,530	19,853	-15.2%	Shares	Sole	2026-07-30
2026-03-31	$222,986	23,423	+20.3%	Shares	Sole	2026-04-30
2025-12-31	$151,889	19,473	-13.2%	Shares	Sole	2026-02-05
2025-09-30	$170,274	22,434	-21.2%	Shares	Sole	2025-11-12
2021-12-31	$394,212	28,463	+0.4%	Shares	Sole	2022-02-03
2021-09-30	$407,576	28,363	-14.7%	Shares	Sole	2021-11-02
2021-06-30	$525,919	33,265	-31.1%	Shares	Sole	2021-08-10
2021-03-31	$491,302	48,309	+14.5%	Shares	Sole	2021-05-07
2020-12-31	$314,352	42,195	+17.3%	Shares	Sole	2021-02-04
2020-09-30	$123,788	35,985	-32.6%	Shares	Sole	2020-10-29
2020-06-30	$254,207	53,405	—	Shares	Sole	2020-07-27
No filing history on record for this holder in this stock.